Loading…
aTyr Pharma, Inc. is projected to rise to $0.5213 by 2027, a +6% move from its current price of $0.492. ATYR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.4706 | $0.4921 | $0.5147 | +0.03% |
| Aug 6 | $0.462 | $0.4923 | $0.5245 | +0.05% |
| Aug 7 | $0.4556 | $0.4924 | $0.5322 | +0.08% |
| Aug 8 | $0.4503 | $0.4925 | $0.5387 | +0.11% |
| Aug 9 | $0.4457 | $0.4927 | $0.5446 | +0.13% |
| Aug 10 | $0.4415 | $0.4928 | $0.55 | +0.16% |
| Aug 11 | $0.4378 | $0.4929 | $0.555 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4378 | $0.4929 | $0.555 | +0.19% |
| Week 2 | $0.4176 | $0.4939 | $0.584 | +0.38% |
| Week 3 | $0.4029 | $0.4948 | $0.6076 | +0.57% |
| Week 4 | $0.391 | $0.4957 | $0.6284 | +0.75% |
| Week 5 | $0.3809 | $0.4966 | $0.6475 | +0.94% |
| Week 6 | $0.3721 | $0.4976 | $0.6653 | +1.13% |
| Week 7 | $0.3642 | $0.4985 | $0.6823 | +1.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
aTyr Pharma, Inc. is a clinical stage biotechnology company that engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. The company is categorized in the Healthcare sector and pursues therapies for fibrotic and inflammatory conditions.
ATYR is a healthcare stock trading under the symbol ATYR. Its current price is $0.4864 and its market capitalization is $47.69M, with a rank of 4292.
A major floor 33.5% below — a decisive break under it would weaken the trend.
The nearest floor, 8.3% below — buyers have tended to step in here.
The nearest ceiling, 32.9% above — a clean break opens room to run.
A major ceiling 111.4% above — clearing it would confirm fresh momentum.
Key ATYR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATYR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.4866 | Buy | $0.4857 | Buy |
| MA 10 | $0.4863 | Buy | $0.4925 | Sell |
| MA 20 | $0.5221 | Sell | $0.5066 | Sell |
| MA 50 | $0.5125 | Sell | $0.5491 | Sell |
| MA 100 | $0.654 | Sell | $0.6691 | Sell |
| MA 200 | $0.7417 | Sell | $1.07 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.35 | Neutral |
| Stoch RSI (14) | 43.58 | Neutral |
| CCI (20) | -55.92 | Neutral |
| Williams %R (14) | -78.69 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -8.99 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 21.31 | Neutral |
| TRIX (15) | -0.34 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 48.46 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 0.48 | Buy |
| ADX (14) | 13.02 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is BEARISH. RSI14 is 40, and the price trades relative to the moving averages with the SMA50 at $0.5411 and the SMA200 at $0.7589. Near-term support sits at $0.44 and resistance at $0.654. The 30-day price range spans from $0.3345 to $0.7074.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.396 | $0.492 | $0.6775 | 0% | Neutral | |
| $0.3917 | $0.5213 | $0.7461 | +6% | Neutral | |
| $0.5037 | $0.7048 | $1.07 | +43% | Bullish | |
| $0.6027 | $0.8793 | $1.39 | +79% | Bullish | |
| $0.5414 | $0.8201 | $1.34 | +67% | Bullish | |
| $0.5498 | $0.8623 | $1.46 | +75% | Bullish | |
| $0.5471 | $0.8869 | $1.54 | +80% | Bullish | |
| $0.517 | $0.8647 | $1.54 | +76% | Bullish | |
| $0.6456 | $1.11 | $2.03 | +126% | Bullish | |
| $0.755 | $1.34 | $2.49 | +172% | Bullish | |
| $0.8324 | $1.70 | $3.44 | +245% | Bullish | |
| $1.35 | $2.99 | $6.85 | +508% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.396 | $0.492 | $0.6299 | +0.00% |
| September 2026 | $0.441 | $0.5311 | $0.6644 | +7.96% |
| October 2026 | $0.4138 | $0.5042 | $0.6416 | -5.07% |
| November 2026 | $0.4007 | $0.4929 | $0.636 | -2.24% |
| December 2026 | $0.4181 | $0.5187 | $0.6775 | +5.23% |
Click any year to see its month-by-month ATYR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ATYR is projected to trade between $0.396 and $0.6775, averaging $0.492 — a potential gain of 0% from today's $0.492. A consolidation phase looks the most probable path here.
aTyr Pharma, Inc.'s 2027 outlook centres on $0.5213, within a $0.3917 to $0.7461 range. That is up +6% on the projected 2026 average. That marks a +6% change versus current levels. Price action looks broadly range-bound.
By 2028, ATYR could reach as high as $1.07, with a base case around $0.7048 and support toward $0.5037 — roughly +43% from $0.492. Buyers look set to stay in control over this stretch.
Expect ATYR to range from $0.6027 to $1.39 through 2029. The $0.8793 average target implies a +79% move from current prices. That is up +25% on the projected 2028 average. Momentum favours further upside here.
The ATYR price prediction for 2030 points to an average of $0.8201 (low $0.5414, high $1.34) — a potential gain of +67% on today's $0.492. Buyers look set to stay in control over this stretch.
In 2031, ATYR is projected to trade between $0.5498 and $1.46, averaging $0.8623 — a potential gain of +75% from today's $0.492. That is up +5% on the projected 2030 average. Momentum favours further upside here.
aTyr Pharma, Inc.'s 2032 outlook centres on $0.8869, within a $0.5471 to $1.54 range. That is up +3% on the projected 2031 average. That marks a +80% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ATYR could reach as high as $1.54, with a base case around $0.8647 and support toward $0.517 — roughly +76% from $0.492. Momentum favours further upside here.
Expect ATYR to range from $0.6456 to $2.03 through 2034. The $1.11 average target implies a +126% move from current prices. That is up +29% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ATYR price prediction for 2035 points to an average of $1.34 (low $0.755, high $2.49) — a potential gain of +172% on today's $0.492. Momentum favours further upside here.
In 2040, ATYR is projected to trade between $0.8324 and $3.44, averaging $1.70 — a potential gain of +245% from today's $0.492. That is up +27% on the projected 2035 average. Buyers look set to stay in control over this stretch.
aTyr Pharma, Inc.'s 2050 outlook centres on $2.99, within a $1.35 to $6.85 range. That is up +76% on the projected 2040 average. That marks a +508% change versus current levels. Momentum favours further upside here.
Investing $1,000 in ATYR today (≈ 2,032.520325 ATYR) could be worth
$6,078.8
+$5,078.8 (+508%) by 2050 · US Dollar
Based on the average projected ATYR price of $2.99 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATYRwould be worth at today's price.
$1,000 invested in ATYR on Jul 31, 2025 (≈ 211.864416 ATYR) would be worth
$104.24
-$895.76 (-89.6%) today · 0.10× · US Dollar
Based on a ATYR entry price of $4.72 vs. today's $0.492.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.473 | $1,040.17 | +4.0% |
| 1 month ago | $0.59 | $833.9 | -16.6% |
| 3 months ago | $0.834 | $589.93 | -41.0% |
| 6 months ago | $0.97 | $507.22 | -49.3% |
| 1 year ago | $4.72 | $104.24 | -89.6% |
| All time (5.0y) ago | $4.72 | $104.24 | -89.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATYR forecast.
Our base-case forecast reaches $0.98 around 2034.
Implied market cap at $0.98: $96.09M
The multi-year forecast shows a bullish tilt with rising average prices from 2026 through 2050. In 2026 the average price is $0.4864, climbing to 2028’s $0.7131 and 2029’s $0.9078, then easing to 2030 at $0.7862. The forecast continues higher, with 2040 averaging $1.66 and 2050 averaging $2.78.
Max forecasts rise to $3.64 in 2040 and to $6.39 in 2050, with long-term bullish sentiment indicated for 2028, 2029, 2030, and beyond.
Tap a question to reveal the answer.
In 2030, the forecast average price is $0.7862, the forecasted min is $0.4866, and the max is $1.36. The forecasted ROI is 61.6% and the sentiment is BULLISH.
The 2026 forecast shows an average price of $0.4864 (the current price) with a min of $0.396 and a max of $0.6972, and a 0% ROI. The outlook turns more positive in 2028 onward, with higher average prices and positive ROIs through 2050, but these are estimates and not guarantees.
Yes, the 2040 forecast max is $3.64, with an average of $1.66. This indicates potential to reach or exceed $2 by 2040 based on the maximum forecast, though the 2040 average remains $1.66 and reflects a range of possibilities.
For 2028, the minimum forecast is $0.4875, the average forecast is $0.7131, and the maximum forecast is $1.13. The forecast sentiment is BULLISH and the ROI is 46.6%.
The current price is $0.4864 and the market cap is $47.69M.
aTyr Pharma, Inc. Community Discussion
0Share your aTyr Pharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.